Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 1, 2004, Pages 81-88

  Frazzoni, M ^a   De Micheli, E ^a   Zentilin, P ^b   Savarino, V ^b  

^a Nuovo Ospedale S Agostino   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGUS MANOMETRY; FEMALE; HEARTBURN; HIATUS HERNIA; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PH; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SMOOTH MUSCLE TONE;

ADULT; ANALYSIS OF VARIANCE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HERNIA, HIATAL; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANOMETRY; MIDDLE AGED;

EID: 3142668886     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01998.x     Document Type: Article

References (28)

1. Kahrilas PJ, Pandolfino JE. Gastroesophageal reflux disease and its complications, including Barrett's metaplasia. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran Gastrointestinal and Liver Disease. Philadelphia: W. B. Saunders, 2002: 599-622.
2. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1-S16.
3. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
4. Frazzoni M, De Micheli E, Savarino V. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther 2003; 18: 1091-8.
5. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. Gut 1999; 45(Suppl. II): II31-6.
6. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-1810.
7. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20.
8. Bate CM, Riley SA, Chapman RWG, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 59-66.
9. Orlando RC. Overview of the mechanisms of gastroesophageal reflux. AM J Med 2001; 111(Suppl.8A): 174S-7S.
10. Hirsch DP, Tytgat GNJ, Boeckxstaens GEE. Review article: transient lower oesophageal sphincter relaxations - a pharma cological target for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 17-26.
11. Sampliner RE, The Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barren's esophagus. Am J Gastroenterol 1998; 93: 1028-32.
12. Frazzoni M, Lonardo A, Grisendi A, et al. Are routine duodenal and antral biopsies useful in the management of 'functional' dyspepsia? A diagnostic and therapeutic study. J Clin Gastroenterol 1993; 17: 101-8.
13. American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998; 114: 579-81.
14. Passaretti S, Zaninotto G, Di Martino N, Leo P, Costantini M, Baldi F. Standards for oesophageal manometry. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD). Dig Liver Dis 2000; 32: 46-55.
15. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997; 336: 924-32.
16. Penagini R, Carmagnola S, Cantu P. Review article: gastrooesophageal reflux disease - pathophysiological issues of clinical relevance. Aliment Pharmacol Ther 2002; 16(Suppl. 4): 65-71.
17. Van Herwaarden MA, Samsom M, Smout AJPM. Excess gastroesophageal reflux in patient with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 2000; 119: 1439-46.
18. Trudgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 2001; 96: 2569-74.
19. Sifrim D, Holloway R, Silny J, et al. Acid, non-acid and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120: 1588-98.
20. Weusten BL, Akkermans LM, van Berge-Henegouwen GP, Smout AJ. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 1995; 108: 1739-14.
21. Simren M, Silny J, Holloway R, Tack J, Janssens J, Sifrim D. Relevance of ineffective oesophageal motility during oesophageal acid clearance. Gut 2003; 52: 784-90.
22. Kahrilas PJ, Qulgley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-6.
23. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-15.
24. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
25. Quigley EMM. New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management. Aliment Pharmacol Ther 2003; 17(Suppl. 2): 43-51.
26. Vaezi MF, Richter JE. Gastro-esophageal reflux disease. Curr Opin Gastroenterol 1997; 13: 327-32.
27. Tack J, Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther 2004; 19(Suppl, 1): 28-34.
28. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 885-92.